Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas

Human Pathology

Volumn 44, Issue 6, 2013, Pages 975-982

  Tsuta, Koji ^a   Mimae, Takahiro ^a   Nitta, Hiroaki ^b   Yoshida, Akihiko ^a   Maeshima, Akiko M ^a   Asamura, Hisao ^a   Grogan, Thomas M ^b   Furuta, Koh ^a   Tsuda, Hitoshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Bright field in situ hybridization; Gene copy number; Insulin like growth factor 1 receptor; Non small cell lung carcinoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; RECEPTOR ANTIBODY; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COPY NUMBER VARIATION; FEMALE; GENE DOSAGE; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SARCOMATOID CARCINOMA; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, IGF TYPE 1; TUMOR MARKERS, BIOLOGICAL;

EID: 84878115726     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.09.002     Document Type: Article

References (34)

1. M.J. Piccart-Gebhart, M. Procter, and B. Leyland-Jones Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 2005 1659 1672
2. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
3. D.R. Clemmons Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer Nat Rev Drug Discov 6 2007 821 833
4. H.M. Khandwala, I.E. McCutcheon, A. Flyvbjerg, and K.E. Friend The effects of insulin-like growth factors on tumorigenesis and neoplastic growth Endocr Rev 21 2000 215 244
5. A. Ouban, P. Muraca, T. Yeatman, and D. Coppola Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas Hum Pathol 34 2003 803 808
6. J. Rodon, V. DeSantos, R.J. Ferry Jr., and R. Kurzrock Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials Mol Cancer Ther 7 2008 2575 2588
7. D.D. Karp, L.G. Paz-Ares, and S. Novello Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer J Clin Oncol 27 2009 2516 2522
8. F. Huang, A. Greer, and W. Hurlburt The mechanisms of differential sensitivity to an insulinlike growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors Cancer Res 69 2009 161 170
9. U. Kaiser, C. Schardt, D. Brandscheidt, E. Wollmer, and K. Havemann Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer J Cancer Res Clin Oncol 119 1993 665 668
10. F. Cappuzzo, L. Toschi, and G. Tallini Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib Ann Oncol 17 2006 1120 1127
11. C.Y. Lee, J.H. Jeon, and H.J. Kim Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis Korean J Intern Med 23 2008 116 120
12. V. Ludovini, G. Bellezza, and L. Pistola High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients Ann Oncol 20 2009 842 849
13. R. Dziadziuszko, D.T. Merrick, and S.E. Witta Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression J Clin Oncol 28 2010 2174 2180
14. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris Pathology and genetics of tumors of the lung, pleura, thymus and heart 2004 IARC Press Lyon (France)
15. W.D. Travis, E. Brambilla, and M. Noguchi International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma J Thorac Oncol 6 2011 244 285
16. K. Tsuta, Y. Tanabe, and A. Yoshida Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung J Thorac Oncol 6 2011 1190 1199
17. Japanese Lung Cancer Society General rule for clinical and pathologic recording of lung cancer 5th ed. 1999 Kanahara Tokyo
18. American Jount Committee on Cancer. TNM classification for lung cancer. Available at: Cancerstaging.org.
19. M. Varella-Garcia Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay Diagn Pathol 1 2006 19
20. T. Fukui, Y. Ohe, and K. Tsuta Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer Clin Cancer Res 14 2008 4751 4757
21. A. Yoshida, K. Tsuta, and H. Nitta Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas J Thorac Oncol 6 2011 1677 1686
22. Y. Gong, E. Yao, and R. Shen High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507) PLoS One 4 2009 e7273
23. A. Hurbin, M. Wislez, and B. Busser Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma J Pathol 225 2011 83 95
24. S. Kakegawa, K. Shimizu, and M. Sugano Clinicopathological features of lung adenocarcinoma with KRAS mutations Cancer 117 2011 4257 4266
25. V. Papa, B. Gliozzo, and G.M. Clark Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer Cancer Res 53 1993 3736 3740
26. J.H. Law, G. Habibi, and K. Hu Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival Cancer Res 68 2008 10238 10246
27. A. Imsumran, Y. Adachi, and H. Yamamoto Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma Carcinogenesis 28 2007 947 956
28. W.J. Chng, A. Gualberto, and R. Fonseca IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma Leukemia 20 2006 174 176
29. J. Ahlen, J. Wejde, and O. Brosjo Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma Clin Cancer Res 11 2005 206 216
30. A.S. Parker, J.C. Cheville, C.A. Janney, and J.R. Cerhan High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas Hum Pathol 33 2002 801 805
31. Y.F. Huang, M.R. Shen, K.F. Hsu, Y.M. Cheng, and C.Y. Chou Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer Br J Cancer 99 2008 1096 1102
32. F.R. Hirsch, M. Varella-Garcia, and P.A. Bunn Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 2003 3798 3807
33. F. Morgillo, J.K. Woo, E.S. Kim, W.K. Hong, and H.Y. Lee Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib Cancer Res 66 2006 10100 10111
34. F. Morgillo, W.Y. Kim, E.S. Kim, F. Ciardiello, W.K. Hong, and H.Y. Lee Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib Clin Cancer Res 13 2007 2795 2803